Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors

Clinical trial NCT07523529 · RECRUITING

Trial details

NCT number: NCT07523529
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Unresectable Metastatic

Start date: 2026-03-02
Primary completion: 2027-04-14
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.